Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials.

导出原文传递

翻译打印收藏纠错

第一作者： Thibault,Mura

第一单位： INSERM-University of Toulouse, UMR1027, Toulouse, France.;Department of Epidemiology and Public Health, CHU Toulouse, Toulouse, France.;Department of Biostatistics, Clinical Epidemiology, Public Health and Innovation in Methodology (BESPIM), CHU Nîmes, University of Montpellier, Nimes, France.

作者： Thibault,Mura ^[1] ; Nicola,Coley ^[2] ; Hélène,Amieva ^[3] ; Claudine,Berr ^[4] ; Audrey,Gabelle ^[4] ; Pierre-Jean,Ousset ^[5] ; Bruno,Vellas ^[5] ; Sandrine,Andrieu ^[2] ; GuidAge/DSA study group*

作者单位： INSERM-University of Toulouse, UMR1027, Toulouse, France.;Department of Epidemiology and Public Health, CHU Toulouse, Toulouse, France.;Department of Biostatistics, Clinical Epidemiology, Public Health and Innovation in Methodology (BESPIM), CHU Nîmes, University of Montpellier, Nimes, France. ^[1] INSERM-University of Toulouse, UMR1027, Toulouse, France.;Department of Epidemiology and Public Health, CHU Toulouse, Toulouse, France. ^[2] Inserm U1219 Bordeaux Population Health Center, Université de Bordeaux, Bordeaux, France. ^[3] INSERM-University of Montpellier, U1061, Montpellier, France.;Memory Resources and Research Center, Department of Neurology, Gui de Chauliac University Hospital, Montpellier, France. ^[4] INSERM-University of Toulouse, UMR1027, Toulouse, France.;Department of Geriatric Medicine, CHU Toulouse, Gerontopole, Toulouse, France. ^[5]

关键词 cognition early clinical trial prediction prodromal Alzheimer's disease

主题词日常生活活动(Activities of Daily Living);老年人(Aged);阿尔茨海默病(Alzheimer Disease);人类(Humans);神经心理学测验(Neuropsychological Tests)

DOI 10.1002/alz.12431

PMID 34482607

发布时间 2022-05-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交